Correction: Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies

por Lawson, Nicola L., Dix, Carly I., Scorer, Paul W., Stubbs, Christopher J., Wong, Edmond, Hutchinson, Liam, McCall, Eileen J., Schimpl, Marianne, DeVries, Emma, Walker, Jill, Williams, Gareth H., Hunt, James, Barker, Craig
Publicado 2019

Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies

por Lawson, Nicola L., Dix, Carly I., Scorer, Paul W., Stubbs, Christopher J., Wong, Edmond, Hutchinson, Liam, McCall, Eileen J., Schimpl, Marianne, DeVries, Emma, Walker, Jill, Williams, Gareth H., Hunt, James, Barker, Craig
Publicado 2019

A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradation

por Fletcher, Alice, Clift, Dean, de Vries, Emma, Martinez Cuesta, Sergio, Malcolm, Timothy, Meghini, Francesco, Chaerkady, Raghothama, Wang, Junmin, Chiang, Abby, Weng, Shao Huan Samuel, Tart, Jonathan, Wong, Edmond, Donohoe, Gerard, Rawlins, Philip, Gordon, Euan, Taylor, Jonathan D., James, Leo, Hunt, James
Publicado 2023

Blocking phospholamban with VHH intrabodies enhances contractility and relaxation in heart failure

por De Genst, Erwin, Foo, Kylie S., Xiao, Yao, Rohner, Eduarde, de Vries, Emma, Sohlmér, Jesper, Witman, Nevin, Hidalgo, Alejandro, Kolstad, Terje R. S., Louch, William E., Pehrsson, Susanne, Park, Andrew, Ikeda, Yasuhiro, Li, Xidan, Mayr, Lorenz M., Wickson, Kate, Jennbacken, Karin, Hansson, Kenny, Fritsche-Danielson, Regina, Hunt, James, Chien, Kenneth R.
Publicado 2022